Current Worldwide Trends in Pediatric Helicobacter pylori Antimicrobial Resistance

被引:12
|
作者
Balas, Reka Borka [1 ]
Melit, Lorena Elena [1 ]
Marginean, Cristina Oana [1 ]
机构
[1] George Emil Palade Univ Med Pharm Sci & Technol, Dept Pediat 1, Gheorghe Marinescu St 38, Targu Mures 540136, Romania
来源
CHILDREN-BASEL | 2023年 / 10卷 / 02期
关键词
Helicobacter pylori; antimicrobial resistance; children; STANDARD TRIPLE THERAPY; SECONDARY ANTIBIOTIC-RESISTANCE; CLARITHROMYCIN RESISTANCE; HIGH PREVALENCE; LEVOFLOXACIN RESISTANCE; ISRAELI CHILDREN; BABA2; GENOTYPES; INFECTION; ADOLESCENTS; ERADICATION;
D O I
10.3390/children10020403
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Helicobacter pylori (H. pylori) has acquired several resistance mechanisms in order to escape the currently used eradication regimens such as mutations that impair the replication, recombination, and transcription of DNA; the antibiotics capability to interact with protein synthesis and ribosomal activity; the adequate redox state of bacterial cells; or the penicillin-binding proteins. The aim of this review was to identify the differences in pediatric H. pylori antimicrobial-resistance trends between continents and countries of the same continent. In Asian pediatric patients, the greatest antimicrobial resistance was found to metronidazole (>50%), probably due to its wide use for parasitic infections. Aside from the increased resistance to metronidazole, the reports from different Asian countries indicated also high resistance rates to clarithromycin, suggesting that ciprofloxacin-based eradication therapy and bismuth-based quadruple therapy might be optimal choices for the eradication of H. pylori in Asian pediatric population. The scarce evidence for America revealed that H. pylori strains display an increased resistance to clarithromycin (up to 79.6%), but not all studies agreed on this statement. Pediatric patients from Africa also presented the greatest resistance rate to metronidazole (91%), but the results in terms of amoxicillin remain contradictory. Nevertheless, the lowest resistance rates in most of the African studies were found for quinolones. Among European children, the most frequent antimicrobial resistance was also noticed for metronidazole and clarithromycin (up to 59% and 45%) but with a predominance for clarithromycin as compared to other continents. The differences in antibiotic use among continents and countries worldwide is clearly responsible for the discrepancies regarding H. pylori antimicrobial-resistance patterns, emphasizing the crucial role of global judicious antibiotic use in order to control the increasing resistance rates worldwide.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] PRIMARY ANTIMICROBIAL RESISTANCE OF HELICOBACTER PYLORI IN BELGIUM
    Vekens, K.
    Vandebosch, S.
    De, Bel A.
    Urbain, D.
    Mana, F.
    ACTA CLINICA BELGICA, 2013, 68 (03): : 183 - 187
  • [22] Helicobacter pylori resistance to current therapies
    Smith, Sinead M.
    O'Morain, Colm
    McNamara, Deirdre
    CURRENT OPINION IN GASTROENTEROLOGY, 2019, 35 (01) : 6 - 13
  • [23] Prevalence of antimicrobial resistance in clinical isolates of Helicobacter pylori in a pediatric population from Portugal
    Cabrita, J
    Oleastro, M
    Matos, R
    Manhente, A
    Cabral, J
    Lopes, AI
    GUT, 1999, 45 : A100 - A100
  • [24] Multicenter survey of antimicrobial resistance in Helicobacter pylori isolates in Greece - Trends of resistance 1998-2018
    Martinez-Gonzalez, B.
    Georgopoulos, S.
    Michopoulos, S.
    Karayiannis, Y.
    Liatsos, C.
    Megraud, F.
    Sgouras, D. N.
    Mentis, A. F.
    HELICOBACTER, 2019, 24
  • [25] Helicobacter pylori Antimicrobial Resistance in a Pediatric Population From the New England Region of the United States
    Herzlinger, Michael
    Dannheim, Katelyn
    Riaz, Muhammad
    Liu, Enju
    Bousvaros, Athos
    Bonilla, Silvana
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (13) : 3458 - +
  • [26] Antimicrobial resistance in Helicobacter pylori isolates from children
    Rerksuppaphol, S
    Hardikar, W
    Midolo, PD
    Ward, P
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2003, 39 (05) : 332 - 335
  • [27] Antimicrobial resistance of Helicobacter pylori in Poland:: a multicentre study
    Dzierzanowska-Fangrat, K
    Rozynek, E
    Celinska-Cedro, D
    Jarosz, M
    Pawlowska, J
    Szadkowski, A
    Budzynska, A
    Nowak, J
    Romanczuk, W
    Prosiecki, R
    Józwiak, P
    Dzieranowska, D
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 (03) : 230 - 234
  • [28] Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018
    Bluemel, B.
    Goelz, H.
    Goldmann, B.
    Grueger, J.
    Hamel, H.
    Loley, K.
    Ludolph, T.
    Meyer, J.
    Miehlke, S.
    Mohr, A.
    Tuffers, K.
    Usadel, H.
    Wagner, S.
    Wenzel, H.
    Wiemer, L.
    Vorreiter, J.
    Eisele, B.
    Hofreuter, D.
    Glocker, E. -O.
    CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (02) : 235 - 239
  • [29] Prevalence of Helicobacter pylori resistance to antimicrobial agents in Japan
    Perezaldana, L
    Kato, M
    Asaka, M
    GASTROINTESTINAL ENDOSCOPY, 2002, 55 (05) : AB192 - AB192
  • [30] Helicobacter pylori:: prevalence of antimicrobial resistance in clinical isolates
    Hooton, C.
    Dempsey, C.
    Keohane, J.
    O'Mahony, S.
    Crosbie, O.
    Lucey, B.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2006, 63 (03) : 113 - 116